HIV-1
Conditions
Interventions
case series:Nil
Sponsors
Guangzhou Eighth People's Hospital / Beijing Ditan Hospital Capital Medical University
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1.HIV-1 infection; 2.who have been informed of all pertinent aspects of the study and have voluntarily signed an informed consent form (patients 18 years of age or older); 3.Initiating treatment with B/F/TAF in accordance with the approved product information.
Exclusion criteria
Exclusion criteria: 1.Patients treated with Biktarvy? outside of the approved prescribing information in China; 2.Concurrent participation in a clinical trial of HIV treatment (except trials not testing investigational medicinal products); 3.Patients who have a contraindication as indicated under prescribing information; 4.Patients planning on leaving the country for an extended period during the study period; 5.Patients deemed by the investigator to be unlikely to maintain regular medical follow-up through at least 48 weeks.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To assess rates of adverse events (AEs) and serious AEs (SAEs);To evaluate HIV-1 RNA suppression, defined as HIV-1 RNA <200 copies/mL, at 12 months after initiating or switching to B/F/TAF; | — |
Countries
China
Contacts
Public ContactEric Wang
Outcome results
None listed